Satisfying all your voyeuristic tendencies, Leslie Arfin has published her diary. She’s actually been doing this for a long time, one entry at a time in her Vice column: Dear Diary is a collection of entries starting from sixth grade and going until age 25.
After every entry, Arfin does an update from a wiser point of view (at the age of 27) and checks in with some of the people she wrote about — those who are still alive anyway.
Anyone who spent their adolescence in the mid-to-late ’90
When a fast-food-type bucket says "Fried Dynamite" on it, I expect it to deliver. Pay attention, OC Fair vendors: balls of fried dynamite sauce (that spicy cooked mayo that sushi restaurants tend to serve scallops in) would be a great greaseball snack.
But the only food in here was...four atomic fireball candies, which Janine and our receptionist Leslie nearly came to blows over (Balls of Fury?). The temporary tattoos, not so much.
Nor is Fried Dynamite the long-lost drug-addicted sibling of N
The company that makes gazillions off its Adderall patent has a message to patients: stop taking Adderall.
But Shire Pharmaceuticals Group PLC's desire has nothing to do with health concerns chronicled in today's feature, "Who's Your Addy?" It revolves around money. The Basingstoke, England, company's patent expires in 2009, at which time the formula will become available as a less-costly generic drug and Shire's Adderall fortunes will plummet. So Shire in February 2007 paid $2.6 billion to ac
UC Irvine pharmacological researchers may have hit on a new way to battle cocaine addiction. Material they shared with Science Daily suggests that blocking a hormone related to hunger regulation can limit coke cravings. A study led by Shinjae Chung and Olivier Civelli zeroed in on how
the melanin-concentrating hormone works with dopamine in the brain's
"pleasure center" to create an addictive response to cocaine use. The
researchers further found that blocking MCH in these brain cells
limited co
Many of Dr. Brian West's patients didn't know he was in the state medical board's substance-abuse-diversion program. At least six of them claim they're paying the price
